ATE130511T1 - Gefriergetrocknete polymerdispersionen und ihre anwendung zur darstellung von arzneimittelzubereitungen mit protrahierter wirkstoffabgabe. - Google Patents
Gefriergetrocknete polymerdispersionen und ihre anwendung zur darstellung von arzneimittelzubereitungen mit protrahierter wirkstoffabgabe.Info
- Publication number
- ATE130511T1 ATE130511T1 AT90105437T AT90105437T ATE130511T1 AT E130511 T1 ATE130511 T1 AT E130511T1 AT 90105437 T AT90105437 T AT 90105437T AT 90105437 T AT90105437 T AT 90105437T AT E130511 T1 ATE130511 T1 AT E130511T1
- Authority
- AT
- Austria
- Prior art keywords
- freeze
- polymer dispersions
- preparation
- application
- active ingredients
- Prior art date
Links
- 229920000642 polymer Polymers 0.000 title abstract 5
- 239000006185 dispersion Substances 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title 2
- 239000004480 active ingredient Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000013583 drug formulation Substances 0.000 abstract 1
- 229920000126 latex Polymers 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 238000005550 wet granulation Methods 0.000 abstract 1
- 238000009736 wetting Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32793489A | 1989-03-23 | 1989-03-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE130511T1 true ATE130511T1 (de) | 1995-12-15 |
Family
ID=23278720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT90105437T ATE130511T1 (de) | 1989-03-23 | 1990-03-22 | Gefriergetrocknete polymerdispersionen und ihre anwendung zur darstellung von arzneimittelzubereitungen mit protrahierter wirkstoffabgabe. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5326572A (de) |
| EP (1) | EP0388954B1 (de) |
| AT (1) | ATE130511T1 (de) |
| CA (1) | CA2012853A1 (de) |
| DE (1) | DE69023682T2 (de) |
| DK (1) | DK0388954T3 (de) |
| ES (1) | ES2079389T3 (de) |
| GR (1) | GR3018970T3 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5968551A (en) | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
| SE9203594D0 (sv) * | 1992-11-30 | 1992-11-30 | Christer Nystroem | Laekemedel i dispersa system |
| DE4244466C2 (de) * | 1992-12-24 | 1995-02-23 | Pharmatech Gmbh | Verfahren zur Herstellung von Pseudolatices und Mikro- oder Nanopartikeln und deren Verwendung zur Herstellung von pharmazeutischen Präparaten |
| IL110014A (en) | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
| US7740881B1 (en) | 1993-07-01 | 2010-06-22 | Purdue Pharma Lp | Method of treating humans with opioid formulations having extended controlled release |
| DE4324474A1 (de) * | 1993-07-21 | 1995-01-26 | Henkel Kgaa | Verwendung ausgewählter Polyvinylacetat-Dispersionen für die Oberflächenverfestigung von Sand und/oder Erdreich |
| US5879705A (en) * | 1993-07-27 | 1999-03-09 | Euro-Celtique S.A. | Sustained release compositions of morphine and a method of preparing pharmaceutical compositions |
| DE4413350A1 (de) | 1994-04-18 | 1995-10-19 | Basf Ag | Retard-Matrixpellets und Verfahren zu ihrer Herstellung |
| DE4423078B4 (de) * | 1994-07-01 | 2005-01-13 | Awd.Pharma Gmbh & Co. Kg | Verfahren zur Herstellung einer Carbamazepin-Arzneiform mit verzögerter Wirkstofffreisetzung |
| US5684121A (en) * | 1994-12-06 | 1997-11-04 | Isp Investments Inc. | N-vinyl lactam polymer containing tablets of low friability and high rate of dissolution |
| ATE251896T1 (de) * | 1994-12-19 | 2003-11-15 | Daiichi Seiyaku Co | Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung |
| US5985313A (en) * | 1997-10-22 | 1999-11-16 | New York Blood Center, Inc. | Method for decreasing the frequency of transmission of viral infections using cellulose acetate phthalate or hydroxypropyl methylcellulose phthalate excipients |
| US6165493A (en) * | 1997-10-22 | 2000-12-26 | New York Blood Center, Inc. | "Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections" |
| US6806294B2 (en) | 1998-10-15 | 2004-10-19 | Euro-Celtique S.A. | Opioid analgesic |
| US10179130B2 (en) | 1999-10-29 | 2019-01-15 | Purdue Pharma L.P. | Controlled release hydrocodone formulations |
| KR100889069B1 (ko) | 1999-10-29 | 2009-03-17 | 유로-셀티크 소시에떼 아노뉨 | 서방성 하이드로코돈 제형 |
| BR0115382A (pt) | 2000-10-30 | 2003-09-16 | Euro Celtique Sa | Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica |
| UA81224C2 (uk) | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| US20110104214A1 (en) | 2004-04-15 | 2011-05-05 | Purdue Pharma L.P. | Once-a-day oxycodone formulations |
| US20040115266A1 (en) * | 2002-02-01 | 2004-06-17 | Namburi Ranga Raju | Oral itraconazole formulations and methods of making the same |
| WO2005000237A2 (en) * | 2003-06-25 | 2005-01-06 | University Of Tennessee Research Foundation | Granules containing biologically active substances |
| US7829148B2 (en) * | 2006-02-07 | 2010-11-09 | Fmc Corporation | Coating process to produce controlled release coatings |
| US20070281016A1 (en) * | 2006-06-06 | 2007-12-06 | Endo Pharmaceuticals Inc., A Delaware Corporation | Sustained release oxycodone composition with acrylic polymer and surfactant |
| US20080075768A1 (en) * | 2006-07-21 | 2008-03-27 | Vaughn Jason M | Hydrophobic opioid abuse deterrent delivery system using opioid antagonists |
| US20080200890A1 (en) * | 2006-12-11 | 2008-08-21 | 3M Innovative Properties Company | Antimicrobial disposable absorbent articles |
| US9555167B2 (en) * | 2006-12-11 | 2017-01-31 | 3M Innovative Properties Company | Biocompatible antimicrobial compositions |
| CN112638995B (zh) | 2018-08-31 | 2024-03-19 | 赢创运营有限公司 | 制备聚合物粉末的方法 |
| CN114456404B (zh) * | 2022-01-24 | 2024-02-13 | 哈尔滨工业大学 | 一种液态金属柔性可穿戴器件及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2800463A (en) * | 1953-05-14 | 1957-07-23 | Shawinigan Resins Corp | Polyvinyl acetate powder and process of making the same |
| US2809192A (en) * | 1954-05-25 | 1957-10-08 | Atlantic Res Corp | Method of making cellulose esters in the form of small, dense, spherical particles |
| US3942261A (en) * | 1973-12-21 | 1976-03-09 | Toyo Ink Manufacturing Co., Ltd. | Method for producing powder paint |
| US4330338A (en) * | 1978-10-02 | 1982-05-18 | Purdue Research Foundation | Pharmaceutical coating composition, and preparation and dosages so coated |
| AU569277B2 (en) * | 1983-03-03 | 1988-01-28 | Dow Chemical Company, The | Aqueuos dispersion of water-insoluble organophilic cellulose ether for sustained release of active agents |
| US4652442A (en) * | 1983-07-05 | 1987-03-24 | Arcana Chem. Pharm. Fabrik Gesellschaft M.B.H. | Process of producing a sustained release preparation containing indomethacin or niomethacin |
| US4968350A (en) * | 1987-04-16 | 1990-11-06 | Christian Bindschaedler | Process for preparing a powder of water-insoluble polymer which can be redispersed in a liquid phase, the resulting powder and utilization thereof |
| US4960814A (en) * | 1988-06-13 | 1990-10-02 | Eastman Kodak Company | Water-dispersible polymeric compositions |
-
1990
- 1990-03-05 US US07/489,166 patent/US5326572A/en not_active Expired - Fee Related
- 1990-03-22 ES ES90105437T patent/ES2079389T3/es not_active Expired - Lifetime
- 1990-03-22 EP EP90105437A patent/EP0388954B1/de not_active Expired - Lifetime
- 1990-03-22 DK DK90105437.9T patent/DK0388954T3/da active
- 1990-03-22 DE DE69023682T patent/DE69023682T2/de not_active Expired - Fee Related
- 1990-03-22 CA CA002012853A patent/CA2012853A1/en not_active Abandoned
- 1990-03-22 AT AT90105437T patent/ATE130511T1/de not_active IP Right Cessation
-
1996
- 1996-02-14 GR GR960400371T patent/GR3018970T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0388954A3 (de) | 1992-09-09 |
| EP0388954A2 (de) | 1990-09-26 |
| DK0388954T3 (da) | 1995-12-18 |
| CA2012853A1 (en) | 1990-09-23 |
| ES2079389T3 (es) | 1996-01-16 |
| US5326572A (en) | 1994-07-05 |
| DE69023682T2 (de) | 1996-04-18 |
| EP0388954B1 (de) | 1995-11-22 |
| DE69023682D1 (de) | 1996-01-04 |
| GR3018970T3 (en) | 1996-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE130511T1 (de) | Gefriergetrocknete polymerdispersionen und ihre anwendung zur darstellung von arzneimittelzubereitungen mit protrahierter wirkstoffabgabe. | |
| US5044091B1 (en) | Method of preparing a freeze-dried formulation of a drug | |
| EP0158277A3 (de) | Implantierbare Zubereitungen von regulatorischen Peptiden mit gesteuerter Freisetzung und Verfahren zur ihrer Herstellung | |
| ATE109000T1 (de) | System zur freisetzung von medikamenten und dessen herstellungsmethode. | |
| SE8104661L (sv) | Stabil mikrokristallin form av cisplatin, forfarande for framstellning derav samt stabil, steril torrblandningsberedning derav | |
| NO870558D0 (no) | Fremgangsmaate for fremstilling av et langsomt frigivende farmasoeytisk preparat. | |
| ATE421318T1 (de) | Darreichungsform, welche rasche dispersionseigenschaften entfaltet, anwendungsverfahren sowie verfahren zur herstellung derselben | |
| JP6816015B2 (ja) | タンパク質またはペプチド伝達用の溶解性マイクロニドル | |
| ATE72629T1 (de) | Cyclosporin enthaltende pharmazeutische zubereitung. | |
| NZ501950A (en) | Medicinal compositions for application to mucosa | |
| DE3789965D1 (de) | Mikrogranuläre zubereitung zur verabreichung biologisch aktiver stoffe in den eingeweideregionen von tieren. | |
| KR890007789A (ko) | 수용성 펩타이드 및 단백질의 생체분해 가능한 마이크로캡슐의 제조방법 및 이 방법에 의해 수득되는 마이크로캡슐 | |
| DE3876756D1 (de) | Vorrichtung zur gesteuerten freigabe und verabreichung von wirkstoffen an tierisches gewebe. | |
| EP0800828A4 (de) | Transmucosale zubereitung | |
| DK1009380T3 (da) | Fremgangsmåde til fremstilling af farmaceutiske formuleringer | |
| FR2613223B1 (fr) | Forme galenique se presentant sous la forme de grains hydrosolubles, en particulier a base d'un extrait sec de ginkgo biloba, et son procede de preparation | |
| HUP9902032A2 (hu) | Peszticid készítmény | |
| ES2018737A6 (es) | Composicion plaguicida mejorada y procedimiento para su preparacion. | |
| EP0680763A3 (de) | Stabile Präparation zur Behandlung von Störungen der Blutgerinnung, die ein aktiviertes Blutgerinnungsfaktor und Lipidvesikeln enthält | |
| NO912748D0 (no) | Fremgangsmaate for fremstilling av vandige blandingsmicelleloesninger. | |
| ATE132877T1 (de) | Emulgatorfreie emulsionspolymere in pharmazeutischen zubereitungen mit verzögerter wirkstofffreigabe und ihre herstellung | |
| CA2025315A1 (en) | Protein-containing aqueous solutions | |
| ATE111731T1 (de) | Pharmazeutische zubereitung zur rektalen verabreichung. | |
| JPS5517326A (en) | Creamy drug for external use, and its preparation | |
| JPH0393716A (ja) | 可溶性コラーゲンパウダーを担体とする粒状医薬徐放剤の製造方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| REN | Ceased due to non-payment of the annual fee |